STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 102 filers reported holding STOKE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,371 | +127.7% | 348,069 | +514.7% | 0.12% | +95.0% |
| Q2 2023 | $602 | +79.2% | 56,626 | +40.3% | 0.06% | +81.8% |
| Q1 2023 | $336 | -49.2% | 40,364 | -43.6% | 0.03% | -59.8% |
| Q4 2022 | $661 | -99.9% | 71,572 | -4.7% | 0.08% | -35.9% |
| Q3 2022 | $965,000 | +13.3% | 75,127 | +85.5% | 0.13% | +12.3% |
| Q1 2022 | $852,000 | +45.1% | 40,495 | +65.5% | 0.11% | +54.1% |
| Q4 2021 | $587,000 | +136.7% | 24,467 | +150.9% | 0.07% | +196.0% |
| Q3 2021 | $248,000 | – | 9,753 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |